🇺🇸 FDA
Patent

US 8221772

Pulmonary surfactant formulations and methods for promoting mucus clearance

granted A61KA61K31/66A61K9/0078

Quick answer

US patent 8221772 (Pulmonary surfactant formulations and methods for promoting mucus clearance) held by Discovery Laboratories, Inc. expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Discovery Laboratories, Inc.
Grant date
Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/66, A61K9/0078, A61P, A61P11/00